Caspofungin acetate, bivalirudin.
D000789:Angina, Unstable / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy; D000077336:Caspofungin; D000075202:Contraindications; D004346:Drug Information Services; D004347:Drug Interactions; D054714:Echinocandins; D005260:Female; D024764:Hirudin Therapy; D006629:Hirudins / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D055666:Lipopeptides; D008297:Male; D010446:Peptide Fragments / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010455:Peptides; D010456:Peptides, Cyclic; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D000935:Antifungal Agents; D054714:Echinocandins; D006629:Hirudins; D055666:Lipopeptides; D010446:Peptide Fragments; D010455:Peptides; D010456:Peptides, Cyclic; D011994:Recombinant Proteins; D000077336:Caspofungin; C074619:bivalirudin